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sponding to the fastest leg run 0.4 m/s slower. The bilateral coordina-
tion of gait was assessed by the Phase Coordination Index (PCI).
Results: During tied condition, the step lengths of the slowest and
fastest leg were respectively 26.563.0 and 34.963.9 cm (p5ns) with
a fastest/slowest ratio of 1.360.5. During the BSR condition these
values resulted respectively 31.164.9 cm, 29.964.0 cm (p5ns) and
1.160.8 (p50.03 vs. tied), thus revealing a more symmetric gait as
compared to the tied condition. During WSR, these values were
respectively 22.562.5 cm, 41.062.8 cm (p50.0003) e 1.860.2
(P50.002 vs tied), thus revealing a more asymmetric gait. However,
when examining the bilateral coordination of the lower limbs, gait
was significantly more coordinated during WSR than during tied
(p50.05) or BSR (p50.02): the PCI values were 39.8610.3,
47.3610.7, and 52.3611.5, respectively. As a consequence the
global performance of gait resulted improved during the WSR as
compared to the tied condition: stride length increased from
61.065.0 to 64.165.9 cm (p50.05) whereas cadence decreased from
147617 to 11869 steps/min (p50.04).
Conclusions: Our findings reveal that during normal gait (tied) the
locomotor system reduces the step length of the less affected side in
order to preserve the symmetry between legs. In fact, during the
WSR condition, in spite of the increased asymmetry, gait improves
in terms of stride length and coordination.
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Objective: To examine specific gait parameters using a wearable
accelerometer system in PD patients as compared with normal
individuals.
Background: Walking is one of the most universal human activ-
ities and disorders of gait are one of the most cumbersome symptoms
in Parkinson’s disease (PD). Quantitative gait analysis using external
devices is particularly relevant to detect and characterize walking dis-
orders, particularly in patients with neurological diseases.
Methods: Ten PD patients (mean age: 6369 years and body mass
index: 2363 kg/m2) and 10 control subjects (mean age: 6469 years
and body mass index: 2462 kg/m2) were included in the study. PD
patients were studied on medication. Mean disease duration was 8
years and mean score on Hoehn & Yahr scale was 2 Participants
were asked to walk at their comfortable speed under standardized ex-
perimental conditions in a 40 m-long hospital corridor. The gait anal-
ysis system used in this study (LocometrixTM) included an accelera-
tion sensor, a recording device and a software for signal processing.
The sensor was composed of two accelerometers placed perpendicu-
larly and was incorporated into a semi-elastic belt placed over the
L3-L4 intervertebral space. We extracted the following gait parame-
ters during a 20-second period of stabilized walking: stride fre-
quency, stride length, stride regularity (similarity of cranio-caudal
movements over successive strides) and step symmetry (similarity of
left and right cranio-caudal movements). Walking speed was also
measured.
Results: Walking speed and stride length were significantly lower
in PD patients in comparison with healthy controls (Table 1). Stride
regularity and step symmetry were also altered in the PD group but
this difference did not reach statistical significance.
Conclusions: Although this study is limited by a small sample
size, our preliminary results showed that quantitative gait parameters
can be easily studied in PD patients using a wearable accelerometer
system. This approach still needs to be validated in PD but opens
interesting perspectives to track modifications of quantitative gait pa-
rameters associated with disease progression and to evaluate more
accurately the effects of specific therapeutic interventions.
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Objective: To monitor physical activity levels and energy expend-
iture in daily life using the ambulatory SenseWear ArmbandTM sys-
tem in Parkinson’s disease (PD) patients and control subjects.
Background: One goal of therapeutic interventions in PD is to
improve the level of mobility and physical activity during daily life
but these important outcomes remain difficult to quantify with a high
accuracy.
Methods: We recruited 11 PD patients (mean age: 63.3367.81
years and B.M.I.: 25.163.24 kg/m2) and 11 control subjects (mean
TABLE 1 (525).
Gait parameters Controls PD p value
Walking speed (m/s) 1.39 6 0.19 1.16 6 0.3 0.05
Stride frequency (Hz) 0.92 6 0.04 0.92 6 0.1 NS
Stride length (m) 1.51 6 0.18 1.26 6 0.26 0.02
Stride regularity (au) 270 6 47 239 6 67 NS
Step symmetry (au) 214 6 52 185 6 79 NS
m5meters; s5seconds; au 5arbitrary unit; NS5not significant.
FIG. 1 (524).
TABLE 1 (526). Parameters derived from 24h ambulatory SenseWear
ArmbandTM recordings
Controls PD P value
TEE 2286 6 563 23366584 NS
0-1 MET
EE (cal) 6876166 8946224 NS
Time (min) 6586163 7686179 NS
1-2 MET
EE (cal) 3926119 5606176 NS
Time (min) 4086163 4246211 NS
2-3 MET
EE (cal) 5626155 3616121 0.002
Time (min) 222674 147655 0.01
3-6 MET
EE (cal) 6286557 5066442 NS
Time (min) 1506103 100680 NS
>6MET
EE (cal) 17620 1264 NS
Time (min) 2.262.4 667 NS
Number of steps 756363194 527961820 0.045
TEE5total energy expenditure (EE); cal5calories; min5minutes.
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